GENERAL INFORMATION
Established:  2004
Type:  Graduated from Technological Incubator
Ownership:  Private
Parent:  Meytav Technological Incubator

Core business

Minimally Invasive Mastopexy.

Employees:  6
Main Markets:  Plastic surgeons, manufacturers and distributors of medical equipment.

Overview

ORBIX MEDICAL LTD. (formerly Minimally Invasive Mastopexy (MIM))
has developed an innovative technology and a breast lift kit that
is intended to revolutionize the field of cosmetic breast
surgery. The MIM surgery procedure is characterized by certain
remarkable features that distinguishes it from all conventional
breast surgery procedures and will make it the most viable and
effective solution in the breast lift surgery market.

ORBIX developed an innovative technology and a kit that is
intended to support and lift soft tissues in different body parts
which require lifting and reshaping from aesthetic and other
reasons. This, by a minimally invasive approach which simplifies
the procedure, reduces recovery period and eliminates scars.

In the first stage, ORBIX is focusing on developing the Cup&Up
kit for solving the breast sagging (ptosis) problem. As women
age, the breasts may begin to sag or become ptotic. This process
is often accelerated by pregnancy and nursing. Mastopexy, or
breast lifting, may be performed to enhance the shape of the
breast and to obtain a more youthful appearance, improved
projection, and reduced ptosis. The Mastopexy procedure is
performed as a stand alone procedure or often as part of a breast
augmentation procedure. The Mastopexy procedure involves massive
interference with both internal and external breast tissues.
Unfortunately, the aesthetic improvement achieved comes at the
cost of noticeable scars and asymmetry. In addition, the
procedure, which is not suitable for the early stage of breast
sagging, is an expensive, long term recovery procedure, with
potential specific risks and complications and short term effect.

The target market for ORBIX's Mastopexy procedure includes the
existing mastopexy market. Since the Cup&Up kit reduces risks and
presents better aesthetic results, MIM expects to replace the
existing breast mastopexy procedure and also to give a better
solution for women afraid of the present mastopexy procedure.
Furthermore, MIM's unique procedure and Cup&Up kit can be used in
conjunction with breast augmentation surgery (which is currently
the most popular of all breast surgery procedures) or breast
reduction procedures, providing an excellent solution for a large
group of women who require breast lift in addition to
augmentation (augmentation-pexy), and/or as a preventive measure
against ptosis process and enhancing the aesthetic effect. It is
also the only solution for early stage of breast sagging and the
only corrective measure for women suffering from Pseudo-ptosis,
an undesirable, post-surgical process usually observed in
postpartum breast atrophy, characterized by inferior pole ptosis
with nipple at or above the inframammary fold.